You are here: All Products  > LaNova of Shanghai Sells Myeloma ADC Rights to AstraZeneca for $600 Million

LaNova of Shanghai Sells Myeloma ADC Rights to AstraZeneca for $600 Million

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products